Medications

Pomalyst approved for advanced multiple myeloma

(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.

Other

'Vanishing twin' explains increased risk of birth defects

Australian researchers have made the significant discovery that loss of a twin during very early pregnancy explains the increased risk of birth defects seen in multiple pregnancies after infertility treatment.

Other

Neonatal intensive care unit offers tips for parents

Imagine babies so tiny a wedding ring can fit around their arms. Often weighing less than a pound, these remarkably small and sick infants hold onto life hooked up to a maze of tubes and beeping monitors. Although no parent ...

page 5 from 7